Bio-Rad Labs (BIO) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $295.15 --0%
EPS Growth %: -30.7%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -30.7%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.97, $0.19 better than the analyst estimate of $0.78. Revenue for the quarter came in at $506.1 million versus the consensus estimate of $494.85 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Macquarie Downgrades Orora Ltd. (ORA:AU) (ORRAF) to Neutral
- ADNOC Distribution agrees to buy Shell's South Africa unit for $1B
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
